Studies of metabolite-protein interactions: a review.

[1]  D. S. Hage,et al.  Review: Glycation of human serum albumin. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[2]  D. S. Hage,et al.  Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin. , 2013, Current Metabolomics.

[3]  Lu Wang,et al.  Stereoselective binding of chiral drugs to plasma proteins , 2013, Acta Pharmacologica Sinica.

[4]  D. S. Hage,et al.  Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin , 2013, Analytical and Bioanalytical Chemistry.

[5]  D. S. Hage,et al.  Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin. , 2013, Analytical chemistry.

[6]  Youhua Xu,et al.  Pre-column incubation followed by fast liquid chromatography analysis for rapid screening of natural methylglyoxal scavengers directly from herbal medicines: case study of Polygonum cuspidatum. , 2013, Journal of chromatography. A.

[7]  Philip Britz-McKibbin,et al.  New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. , 2013, Chemical reviews.

[8]  D. S. Hage,et al.  Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin. , 2012, Journal of chromatography. A.

[9]  M. Snyder,et al.  Investigating metabolite-protein interactions: an overview of available techniques. , 2012, Methods.

[10]  V. Trezza,et al.  Human serum albumin: from bench to bedside. , 2012, Molecular aspects of medicine.

[11]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[12]  D. S. Hage,et al.  Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography , 2012, Analytical and Bioanalytical Chemistry.

[13]  Caroline H. Johnson,et al.  Xenobiotic metabolomics: major impact on the metabolome. , 2012, Annual review of pharmacology and toxicology.

[14]  D. S. Hage,et al.  Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling. , 2011, Journal of chromatography. A.

[15]  D. S. Hage,et al.  High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin , 2011, Analytical and bioanalytical chemistry.

[16]  D. S. Hage,et al.  CHROMATOGRAPHIC ANALYSIS OF DRUG INTERACTIONS IN THE SERUM PROTEOME. , 2011, Analytical methods : advancing methods and applications.

[17]  Michael J. Kimzey,et al.  New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism. , 2011, Chemico-Biological Interactions.

[18]  D. S. Hage,et al.  Characterization of drug interactions with serum proteins by using high-performance affinity chromatography. , 2011, Current drug metabolism.

[19]  Jeffrey M Peters,et al.  Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  D. S. Hage,et al.  Binding of tolbutamide to glycated human serum albumin. , 2011, Journal of pharmaceutical and biomedical analysis.

[21]  D. S. Hage,et al.  Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[22]  Kevin Y. Yip,et al.  Extensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses , 2010, Cell.

[23]  Liang-Hong Guo,et al.  Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins. , 2010, Toxicology.

[24]  D. S. Hage,et al.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. , 2010, Journal of pharmaceutical and biomedical analysis.

[25]  D. S. Hage,et al.  Chromatographic analysis of acetohexamide binding to glycated human serum albumin. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[26]  Benjamin P Bowen,et al.  Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging. , 2010, BioTechniques.

[27]  J. Ramos,et al.  Compartmentalized Glucose Metabolism in Pseudomonas putida Is Controlled by the PtxS Repressor , 2010, Journal of bacteriology.

[28]  D. S. Hage,et al.  Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[29]  Julie Schappler,et al.  Drug–protein binding: a critical review of analytical tools , 2010, Analytical and bioanalytical chemistry.

[30]  Thomas Hoffmann,et al.  CE‐ESI‐MS/MS as a rapid screening tool for the comparison of protein–ligand interactions , 2010, Electrophoresis.

[31]  W. Zheng,et al.  The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability in vitro. , 2010, Journal of veterinary pharmacology and therapeutics.

[32]  A. Stokes,et al.  Online quench-flow electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for elucidating kinetic and chemical enzymatic reaction mechanisms. , 2010, Analytical chemistry.

[33]  D. S. Hage,et al.  Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography. , 2010, Analytical biochemistry.

[34]  Hao Sun,et al.  Structure‐based Drug Metabolism Predictions for Drug Design , 2010, Chemical biology & drug design.

[35]  M. D. de Groot,et al.  Understanding CYP2D6 interactions. , 2009, Drug discovery today.

[36]  John E. Schiel,et al.  Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography. , 2009, Journal of chromatography. A.

[37]  D. S. Hage,et al.  Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: Analysis by high-performance affinity chromatography. , 2009, Journal of separation science.

[38]  I. Wainer,et al.  Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC). , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[39]  Hideyuki Suzuki,et al.  Characterization of orphan monooxygenases by rapid substrate screening using FT-ICR mass spectrometry. , 2008, Chemistry & biology.

[40]  N. Lopes,et al.  Characterization of interactions between polyphenolic compounds and human serum proteins by capillary electrophoresis , 2008, Analytical and bioanalytical chemistry.

[41]  A. Foroumadi,et al.  Enantioselective determination of tramadol and its main phase I metabolites in human plasma by high-performance liquid chromatography. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[42]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[43]  D. J. Veldhuisen,et al.  Advanced glycation end‐products (AGEs) and heart failure: Pathophysiology and clinical implications , 2007, European journal of heart failure.

[44]  F. B. Davis,et al.  Molecular modeling of the thyroid hormone interactions with αvβ3 integrin , 2007, Steroids.

[45]  F. Ceciliani,et al.  The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. , 2007, Current protein & peptide science.

[46]  Anne Hersey,et al.  Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. , 2006, Journal of medicinal chemistry.

[47]  M. Otagiri,et al.  Chain length-dependent binding of fatty acid anions to human serum albumin studied by site-directed mutagenesis. , 2006, Journal of molecular biology.

[48]  K. Comess,et al.  An Ultraefficient Affinity-Based High-Throughout Screening Process: Application to Bacterial Cell Wall Biosynthesis Enzyme MurF , 2006, Journal of biomolecular screening.

[49]  S. Curry,et al.  Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. , 2006, Journal of molecular biology.

[50]  G. Cooper,et al.  A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[51]  D. S. Hage,et al.  Studies by biointeraction chromatography of binding by phenytoin metabolites to human serum albumin. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[52]  Harald Schwalbe,et al.  Biomolecular NMR: a chaperone to drug discovery , 2006, Current Opinion in Chemical Biology.

[53]  Fernand Labrie,et al.  Comparison of crystal structures of human androgen receptor ligand‐binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity , 2006, Protein science : a publication of the Protein Society.

[54]  Harald Schwalbe,et al.  NMR characterization of kinase p38 dynamics in free and ligand-bound forms. , 2006, Angewandte Chemie.

[55]  S. Curry,et al.  Locating high-affinity fatty acid-binding sites on albumin by x-ray crystallography and NMR spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Andrea Giachetti,et al.  Combining in silico tools and NMR data to validate protein-ligand structural models: application to matrix metalloproteinases. , 2005, Journal of medicinal chemistry.

[57]  Mahavir Singh,et al.  Monitoring the effects of antagonists on protein-protein interactions with NMR spectroscopy. , 2005, Journal of the American Chemical Society.

[58]  U. Karst,et al.  Monitoring enzymatic conversions by mass spectrometry: a critical review , 2005, Analytical and bioanalytical chemistry.

[59]  John E. Schiel,et al.  Analysis of free hormone fractions by an ultrafast immunoextraction/displacement immunoassay: studies using free thyroxine as a model system. , 2005, Analytical chemistry.

[60]  Philip Doble,et al.  Chiral analysis of methadone and its major metabolites (EDDP and EMDP) by liquid chromatography-mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[61]  David R. Liu,et al.  In vitro characterization of IroB, a pathogen-associated C-glycosyltransferase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[63]  D. S. Hage,et al.  Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[64]  N. Pohl,et al.  Discovery of the chemical function of glycosidases: design, synthesis, and evaluation of mass-differentiated carbohydrate libraries. , 2004, Organic letters.

[65]  Lee Makowski,et al.  RELIC – A bioinformatics server for combinatorial peptide analysis and identification of protein‐ligand interaction sites , 2004, Proteomics.

[66]  R. Falchetto,et al.  SpeedScreen: label-free liquid chromatography-mass spectrometry-based high-throughput screening for the discovery of orphan protein ligands. , 2004, Analytical biochemistry.

[67]  M. Sugawara,et al.  Differential binding of disopyramide and warfarin enantiomers to human alpha(1)-acid glycoprotein variants. , 2003, British journal of clinical pharmacology.

[68]  Stephen Naylor,et al.  Parallel determination of multiple protein metabolite interactions using cell extract, protein microarrays and mass spectrometric detection. , 2003, Rapid communications in mass spectrometry : RCM.

[69]  R. Palmer,et al.  X-ray crystallographic studies of protein-ligand interactions. , 2003, Biochemical Society transactions.

[70]  S. Todo,et al.  Age- and gender-related differences in carbohydrate concentrations of α1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities , 2002, European Journal of Clinical Pharmacology.

[71]  Manfred Kansy,et al.  Predicting plasma protein binding of drugs: a new approach. , 2002, Biochemical pharmacology.

[72]  M. Otagiri,et al.  How Do Fatty Acids Cause Allosteric Binding of Drugs to Human Serum Albumin? , 2002, Pharmaceutical Research.

[73]  Carlo Bertucci,et al.  Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. , 2002, Current medicinal chemistry.

[74]  A. Kleinfeld,et al.  Stopped-flow kinetic analysis of long-chain fatty acid dissociation from bovine serum albumin. , 2002, The Biochemical journal.

[75]  A. Cleton,et al.  Evaluation of the human serum albumin column as a discovery screening tool for plasma protein binding. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[76]  D. S. Hage,et al.  High-performance affinity chromatography: a powerful tool for studying serum protein binding. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[77]  Tomoko Kimura,et al.  Binding study of desethyloxybutynin using high-performance frontal analysis method. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[78]  R. Kaliszan,et al.  Quantitative structure-retention relationships in affinity high-performance liquid chromatography. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[79]  J. Schaffer Fatty acid transport: the roads taken. , 2002, American journal of physiology. Endocrinology and metabolism.

[80]  Yukihiro Kuroda,et al.  Frontal analysis of drug-plasma lipoprotein binding using capillary electrophoresis. , 2002, Journal of pharmaceutical and biomedical analysis.

[81]  S. Curry,et al.  Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. , 2001, Journal of molecular biology.

[82]  J. B. Pitner,et al.  Using receptor conformational change to detect low molecular weight analytes by surface plasmon resonance. , 2001, Analytical chemistry.

[83]  Yukihiro Kuroda,et al.  Effect of oxidation of low‐density lipoprotein on drug binding affinity studied by high performance frontal analysis‐capillary electrophoresis , 2001, Electrophoresis.

[84]  P. Darnerud,et al.  Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice , 2001, Archives of Toxicology.

[85]  D. S. Hage,et al.  Analysis of free drug fractions by ultrafast immunoaffinity chromatography. , 2001, Analytical chemistry.

[86]  Yukihiro Kuroda,et al.  Role of Biantennary Glycans and Genetic Variants of Human α1-Acid Glycoprotein in Enantioselective Binding of Basic Drugs as Studied by High Performance Frontal Analysis/capillary Electrophoresis , 2001, Pharmaceutical Research.

[87]  M. Landoni,et al.  Pharmacology of chiral compounds: 2-arylpropionic acid derivatives. , 2001, Current drug metabolism.

[88]  D. Greenblatt,et al.  Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. , 2001, British journal of anaesthesia.

[89]  D. S. Hage Chromatographic and electrophoretic studies of protein binding to chiral solutes. , 2001, Journal of chromatography. A.

[90]  S. Curry,et al.  Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.

[91]  A. Gergely,et al.  Optical resolution of a series of potential cholecystokinin antagonist 4(3H)-quinazolone derivatives by chiral liquid chromatography on alpha1-acid glycoprotein stationary phase. , 2000, Journal of chromatographic science.

[92]  H Roos,et al.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. , 2000, Journal of medicinal chemistry.

[93]  Yukihiro Kuroda,et al.  Enantioselective binding analysis of verapamil to plasma lipoproteins by capillary electrophoresis-frontal analysis. , 2000, Journal of chromatography. A.

[94]  D. S. Hage,et al.  High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[95]  G L Hammond,et al.  Crystal structure of human sex hormone‐binding globulin: steroid transport by a laminin G‐like domain , 2000, The EMBO journal.

[96]  A. Karlsson,et al.  Enantiomeric separation of amino alcohols on protein phases using statistical experimental design. A comparative study. , 2000, Journal of chromatography. A.

[97]  Yukihiro Kuroda,et al.  Binding analysis of nilvadipine to plasma lipoproteins by capillary electrophoresis-frontal analysis. , 1999, Journal of pharmaceutical and biomedical analysis.

[98]  Paul J Thornalley,et al.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. , 1999, The Biochemical journal.

[99]  M. Miyabe,et al.  Effect of plasma alpha1-acid glycoprotein concentration on the accumulation of lidocaine metabolites during continuous epidural anesthesia in infants and children. , 1999, International journal of clinical pharmacology and therapeutics.

[100]  R. Kaliszan Chromatography and capillary electrophoresis in modelling the basic processes of drug action , 1999 .

[101]  D. S. Hage,et al.  Affinity chromatography: a review of clinical applications. , 1999, Clinical chemistry.

[102]  J. McLachlan,et al.  Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. , 1999, Environmental health perspectives.

[103]  P. Gozzi,et al.  Serum protein binding of tolterodine and its major metabolites in humans and several animal species , 1999, Biopharmaceutics & drug disposition.

[104]  C. Chambon,et al.  Photoaffinity labeling of homologous Met-133 and Met-139 amino acids of rabbit and sheep sex hormone-binding globulins with the unsubstituted Delta 6-testosterone photoreagent. , 1998, Biochemistry.

[105]  C. Bertucci,et al.  Chemical modification of human albumin at cys34 by ethacrynic acid: structural characterisation and binding properties. , 1998, Journal of pharmaceutical and biomedical analysis.

[106]  T. Ferenci,et al.  Effect of Slow Growth on Metabolism of Escherichia coli, as Revealed by Global Metabolite Pool (“Metabolome”) Analysis , 1998, Journal of bacteriology.

[107]  D. S. Hage,et al.  Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[108]  R. Kaliszan Retention data from affinity high-performance liquid chromatography in view of chemometrics. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[109]  P. Brick,et al.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.

[110]  F Baganz,et al.  Systematic functional analysis of the yeast genome. , 1998, Trends in biotechnology.

[111]  K. Wasan,et al.  Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. , 1998, Journal of pharmaceutical sciences.

[112]  D. S. Hage,et al.  Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[113]  D. S. Hage,et al.  Effect of mobile phase composition on the binding kinetics of chiral solutes on a protein-based high-performance liquid chromatography column: interactions of D- and L-tryptophan with immobilized human serum albumin. , 1997, Journal of chromatography. A.

[114]  B. J. Danzo,et al.  Environmental xenobiotics may disrupt normal endocrine function by interfering with the binding of physiological ligands to steroid receptors and binding proteins. , 1997, Environmental health perspectives.

[115]  R. Kaliszan,et al.  Quantitative structure-retention relationships in the examination of the topography of the binding site of antihistamine drugs on alpha 1-acid glycoprotein. , 1996, Journal of chromatography. A.

[116]  T. Peters,et al.  All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .

[117]  R. Kaliszan,et al.  Binding site for basic drugs on alpha 1-acid glycoprotein as revealed by chemometric analysis of biochromatographic data. , 1995, Biomedical chromatography : BMC.

[118]  D. S. Hage,et al.  Characterization of thyroxine-albumin binding using high-performance affinity chromatography. II. Comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin. , 1995, Journal of chromatography. B, Biomedical applications.

[119]  A. Kleinfeld,et al.  Unbound free fatty acid levels in human serum. , 1995, Journal of lipid research.

[120]  D. S. Hage,et al.  Chiral separation mechanisms in protein-based HPLC columns. 2. Kinetic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. , 1994, Analytical chemistry.

[121]  G. Hammond,et al.  Steroid-binding and dimerization domains of human sex hormone-binding globulin partially overlap: steroids and Ca2+ stabilize dimer formation. , 1994, Biochemistry.

[122]  Roman Kaliszan,et al.  CHEMOMETRIC ANALYSIS OF BIOCHROMATOGRAPHIC DATA : IMPLICATIONS FOR MOLECULAR PHARMACOLOGY , 1994 .

[123]  A. Buciński,et al.  Quantitative relationships between the structure of beta-adrenolytic and antihistamine drugs and their retention on an alpha 1-acid glycoprotein HPLC column. , 1994, Biomedical chromatography : BMC.

[124]  Irving W. Wainer,et al.  Enantioselective high-performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for high-performance liquid chromatographic chiral stationary phases , 1994 .

[125]  N. Kerkvliet,et al.  Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice. , 1994, Toxicology.

[126]  D. S. Hage,et al.  Characterization of the binding and chiral separation of D- and L-tryptophan on a high-performance immobilized human serum albumin column. , 1993, Journal of chromatography.

[127]  P. Pétra,et al.  Localization of the steroid‐binding site of the human sex steroid‐binding protein of plasma (SBP or SHBG) by site‐directed mutagenesis , 1992, FEBS letters.

[128]  W. P. Purcell,et al.  Mechanism of retention of benzodiazepines in affinity, reversed-phase and adsorption high-performance liquid chromatography in view of quantitative structure retention relationships , 1992 .

[129]  J. Hermansson,et al.  Chiral high-performance liquid chromatographic separations of vinca alkaloid analogues on alpha 1-acid glycoprotein and human serum albumin columns. , 1992, Journal of chromatography.

[130]  D. S. Hage,et al.  Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin. , 1992, Journal of chromatography.

[131]  I. Wainer,et al.  Stereochemical aspects of benzodiazepine binding to human serum albumin. II. Quantitative relationships between structure and enantioselective retention in high performance liquid affinity chromatography. , 1992, Molecular pharmacology.

[132]  T. Blachère,et al.  Characterization of Met-139 as the photolabeled amino acid residue in the steroid binding site of sex hormone binding globulin using delta 6 derivatives of either testosterone or estradiol as unsubstituted photoaffinity labeling reagents. , 1992, Biochemistry.

[133]  D. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1992, Nature.

[134]  D. S. Hage,et al.  Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. , 1992, Journal of chromatography.

[135]  Roman Kaliszan,et al.  Quantitative structure-enationselective retention relationships for the chromatography of 1,4-benzodiazepines on a human serum albumin based HPLC chiral stationary phase: An approach to the computational prediction of retention and enantioselectivity , 1992 .

[136]  G. Hammond,et al.  Structure/function analyses of human sex hormone‐binding globulin by site‐directed mutagenesis , 1992, FEBS letters.

[137]  I. Wainer,et al.  The in Situ Acetylation of an Immobilized Human Serum Albumin Chiral Stationary Phase for High-Performance Liquid Chromatography in the Examination of Drug–Protein Binding Phenomena , 1992, Pharmaceutical Research.

[138]  F. Jamali,et al.  Enantioselective aspects of drug action and disposition: therapeutic pitfalls. , 1989, Journal of pharmaceutical sciences.

[139]  D. Drayer Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview , 1986, Clinical pharmacology and therapeutics.

[140]  T. Kwong Free drug measurements: methodology and clinical significance. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[141]  J. P. Jeanniot,et al.  Protein binding of propisomide. , 1985, Journal of pharmaceutical sciences.

[142]  Y. Imamura,et al.  Effect of simultaneous administration of drugs on absorption and excretion. XIX. Binding of acetohexamide and its major metabolite, (-)-hydroxyhexamide, to human serum albumin. , 1985, Chemical & pharmaceutical bulletin.

[143]  A. Lehninger Principles of Biochemistry , 1984 .

[144]  E. Baulieu,et al.  Hormonal and immunological aspects of the phylogeny of sex steroid binding plasma protein. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[145]  J. Tillement,et al.  The distribution of bound propranolol between the different human serum proteins. , 1980, Molecular pharmacology.

[146]  G. Sudlow,et al.  Further characterization of specific drug binding sites on human serum albumin. , 1976, Molecular pharmacology.

[147]  A A Spector,et al.  Fatty acid binding to plasma albumin. , 1975, Journal of lipid research.

[148]  David C. Anderson,et al.  SEX‐HORMONE‐BINDING GLOBULIN , 1974, Clinical endocrinology.

[149]  T. Maung on in C , 2010 .

[150]  M. S. Gonçalves,et al.  Fluorescent labeling of biomolecules with organic probes. , 2009, Chemical reviews.

[151]  E. Domenici,et al.  Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. , 2006, Chirality.

[152]  Richard A. Lerner,et al.  Crystal structure of a bacterial cocaine esterase , 2002, Nature Structural Biology.

[153]  J A Sherratt,et al.  Lipoprotein oxidation and its significance for atherosclerosis: A mathematical approach , 2002, Bulletin of mathematical biology.

[154]  M. Saraste,et al.  FEBS Lett , 2000 .

[155]  T. Ferenci,et al.  Assessing the effect of reactive oxygen species on Escherichia coli using a metabolome approach. , 1999, Redox report : communications in free radical research.

[156]  I. Tabas,et al.  Nonoxidative modifications of lipoproteins in atherogenesis. , 1999, Annual review of nutrition.

[157]  U. Westphal Steroid-Protein Interactions II , 1986, Monographs on Endocrinology.

[158]  N. Tietz,et al.  Textbook of clinical chemistry , 1986 .

[159]  G. Nelson Blood Constituents. (Book Reviews: Blood Lipids and Lipoproteins. Quantitation, Composition, and Metabolism) , 1972 .

[160]  Ulrich Westphal,et al.  Steroid-Protein Interactions , 1971, Monographs on Endocrinology.

[161]  H. Kubinyi,et al.  Medicinal Chemistry , 1963, Nature.